MEDICINA
Departamento
Novartis (Sweden)
Täby, SueciaPublicaciones en colaboración con investigadores/as de Novartis (Sweden) (4)
2024
-
Unmet clinical needs, burden of disease and treatment patterns in hidradenitis suppurativa: Real-world experience from Spain
JEADV Clinical Practice, Vol. 3, Núm. 1, pp. 347-357
2023
-
International Hidradenitis Suppurativa Severity Scoring System (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging: A post hoc analysis of the SUNRISE and SUNSHINE phase 3 trials of secukinumab
Journal of the European Academy of Dermatology and Venereology
2020
-
COPD clinical control as a predictor of future exacerbations: Concept validation in the SPARK study population
Thorax, Vol. 75, Núm. 4, pp. 351-353
2019
-
Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized transform study
Transplantation, Vol. 103, Núm. 9, pp. 1953-1963